Last reviewed · How we verify
NCT03154151
Online Therapy for Posttraumatic Stress Symptoms in WTC Responders and Survivors
NA trial testing Online Cognitive-Behavioral Therapy in Post-Traumatic Stress Disorder in 105 participants. Completed in 10 August 2021.
20 May 2021
Quick facts
| Lead sponsor | Icahn School of Medicine at Mount Sinai |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 105 |
| Start date | 21 August 2017 |
| Primary completion | 20 May 2021 |
| Estimated completion | 10 August 2021 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Online Cognitive-Behavioral Therapy
- Online Supportive Therapy
Conditions studied
- Post-Traumatic Stress Disorder — all drugs for Post-Traumatic Stress Disorder →
Sponsor
Icahn School of Medicine at Mount Sinai
Who can join
18 and older, any sex, with Post-Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
If you worked or volunteered as a WTC rescue, recovery or clean-up worker after the 9/11 attacks, or are a survivor of the WTC 9/11 attacks, and you are still experiencing Posttraumatic Stress Disorder (PTSD) symptoms related to your WTC experience, you might be eligible to participate in this clinical trial of therapist-assisted, Internet-based (online) writing therapy for WTC responders and survivors with persistent PTSD symptoms. This study is for WTC responders and survivors who are not currently receiving psychotherapy/counseling. In this study, the researchers aim to find out if Internet-based therapy can help WTC responders and survivors who are still experiencing PTSD symptoms.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Internet-Delivered Cognitive Behavioural Therapy for Post-traumatic Stress Disorder or Acute Stress Disorder: A Health Technology Assessment.
Ontario Health (Quality) . · · 2021 · cited 3× · PMID 34527087
Verify or expand the search:
- PubMed search for NCT03154151
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-Traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06332209 — Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico · NA · recruiting
- NCT06117306 — MDMA-assisted Massed Prolonged Exposure for PTSD · Phase 3 · recruiting
- NCT06002633 — Approach-Avoidance and Alcohol Challenge Study in PTSD · NA · recruiting
- NCT05254405 — An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder · Phase 4 · recruiting
- NCT04152993 — Responsive Neurostimulation for Post-Traumatic Stress Disorder · EARLY_PHASE1 · recruiting
Other Icahn School of Medicine at Mount Sinai trials
Trials by the same sponsor.
- NCT07094308 — The LIFT-ECHO Last Mile Project · NA · not yet recruiting
- NCT07291427 — Chronic Subdural Hematoma Embolization With Detachable Coils · not yet recruiting
- NCT07194187 — High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction · NA · not yet recruiting
- NCT07260916 — Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation · NA · not yet recruiting
- NCT07487948 — Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03154151 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai
- Last refreshed: 25 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03154151.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing